Secondary prevention therapies in acute coronary syndrome and relation to outcomes: observational study.
Clara K ChowDavid BriegerMark RyanNadarajah KangaharanKarice K HyunTom Briffa
Published in: Heart Asia (2019)
Use of secondary prevention therapies diminishes over time following an ACS. Patients receiving secondary prevention had decreased rates of death and MACE at 2 years.